Fcγ receptors as regulators of immune responses
The DOI matches its Crossref record; 138 of the 139 references it cites were found in a registry or an index.
Abstract
In addition to their role in binding antigen, antibodies can regulate immune responses through interacting with Fc receptors (FcRs). In recent years, significant progress has been made in understanding the mechanisms that regulate the activity of IgG antibodies in vivo. In this Review, we discuss recent studies addressing the multifaceted roles of FcRs for IgG (FcgammaRs) in the immune system and how this knowledge could be translated into novel therapeutic strategies to treat human autoimmune, infectious or malignant diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“FcγR activation induces macrophage phagocytosis.44”
From Intestinal B cells license metabolic T-cell activation in NASH microbiota/antigen-independently and contribute to fibrosis by IgA-FcR signalling (2023) · cites this paper as [44]
Citations
Cites
Cartron, G., Dacheux, L., Salles, G., Solal-Celigny, P., Bardos, P., Colombat, P., & Watier, H. (2002) · Blood · doi:10.1182/blood.v99.3.754 · Cited by 1,900
Dendritic Cells Induce Peripheral T Cell Unresponsiveness under Steady State Conditions in Vivo
Hawiger, D., Inaba, K., Dorsett, Y., Guo, M., Mahnke, K., Rivera, M., Ravetch, J. V., Steinman, R. M., & Nussenzweig, M. C. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.769 · Cited by 1,848
Self-citationShields, R. L., Lai, J., Keck, R., O'Connell, L. Y., Hong, K., Meng, Y. G., Weikert, S. H. A., & Presta, L. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202069200 · Cited by 1,835
Anti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation
Kaneko, Y., Nimmerjahn, F., & Ravetch, J. V. (2006) · Science · doi:10.1126/science.1129594 · Cited by 1,754 · cited 1×
“Evidence that this sugar residue is involved in immune regulatory processes was obtained by studying the mechanism of the anti-inflammatory activity of IVIG therap”
BackgroundSelf-citationDifferential Antigen Processing by Dendritic Cell Subsets in Vivo
Dudziak, D., Kamphorst, A. O., Heidkamp, G. F., Buchholz, V. R., Trumpfheller, C., Yamazaki, S., Cheong, C., Liu, K., Lee, H.-W., Park, C. G., et al. (2007) · Science · doi:10.1126/science.1136080 · Cited by 1,455
Deisenhofer, J. (1981) · PubMed · Cited by 1,422
Shinkawa, T., Nakamura, K., Yamane, N., Shoji-Hosaka, E., Kanda, Y., Sakurada, M., Uchida, K., Anazawa, H., Satoh, M., Yamasaki, M., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210665200 · Cited by 1,413
Deisenhofer, J. (1981) · Biochemistry · doi:10.1021/bi00512a001 · Cited by 1,333
The Impact of Glycosylation on the Biological Function and Structure of Human Immunoglobulins
Arnold, J. N., Wormald, M. R., Sim, R. B., Rudd, P. M., & Dwek, R. A. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141702 · Cited by 1,307 · cited 1×
“This sugar side chain consists of a conserved biantennary heptasaccharide core structure containing mannose and N-acetylglucosamine (GlcNac) with varying additions of terminal and branching residues such as fucose, GlcNac, galactose and sialic aci”
BackgroundWeng, W.-K., & Levy, R. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.05.013 · Cited by 1,300 · cited 1×
“Several studies of lymphoma patients who had received Rituximab, a B-cell depleting chimeric IgG1 antibody that is specific for CD20, revealed that those patients with activating FcγR alleles that had a higher binding affinity for the Fc fragment of the therapeutic antibody displayed significantly improved clinical re…”
Background
Cited by
Items 801–900 of 1,008
IgG Fc N-glycosylation: Alterations in neurologic diseases and potential therapeutic target?
Kronimus, Y., Dodel, R. C., Galuska, S. P., & Neumann, S. (2018) · Journal of Autoimmunity · doi:10.1016/j.jaut.2018.10.006 · Cited by 52
Mechanisms of Resistance to Monoclonal Antibodies (mAbs) in Lymphoid Malignancies
Torka, P., Barth, M. J., Ferdman, R., & Hernandez‐Ilizaliturri, F. J. (2019) · Current Hematologic Malignancy Reports · doi:10.1007/s11899-019-00542-8 · Cited by 48
Chang, C., Wu, C.-Y., Dai, M., Chan, H., Wu, W.-S., Su, S., Lin, Y.-Y., Lien, T.-S., Sun, D., & Chang, H. (2015) · Thrombosis and Haemostasis · doi:10.1160/th14-07-0637 · Cited by 50
Moreno-Vicente, J., Willoughby, J. E., Taylor, M. C., Booth, S. G., English, V., Williams, E. L., Penfold, C. A., Mockridge, C. I., Inzhelevskaya, T., Kim, J., et al. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-003735 · Cited by 50
Szili, D., Cserhalmi, M., Bankó, Z., Nagy, G., Szymkowski, D. E., & Sármay, G. (2014) · mAbs · doi:10.4161/mabs.28841 · Cited by 46
“4 Dysfunction of FcγRIIb is critical in the development of autoimmune diseases such as RA.(3,24,25) B cells play crucial roles in RA, for example, by producing auto-antibodies against citrullinated self proteins.”
BackgroundInfluentialGlycans in Sera of Amyotrophic Lateral Sclerosis Patients and Their Role in Killing Neuronal Cells
Edri‐Brami, M., Rosental, B., Hayoun, D., Welt, M., Rosen, H., Wirguin, I., Nefussy, B., Drory, V. E., Porgador, A., & Lichtenstein, R. G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035772 · Cited by 49
“The human FccR family consists of the activating receptor FccRIIIA (CD16) that mediates antibody-dependent cellular cytotoxicity (ADCC) [2].”
BackgroundTRIM21 Immune Signaling Is More Sensitive to Antibody Affinity Than Its Neutralization Activity
Foss, S., Watkinson, R. E., Grevys, A., McAdam, M. B., Bern, M., Høydahl, L. S., Dalhus, B., Michaelsen, T. E., Sandlie, I., James, L. C., et al. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1502601 · Cited by 48
Therapeutic antibody targeting of indoleamine-2,3-dioxygenase (IDO2) inhibits autoimmune arthritis
Merlo, L. M. F., Grabler, S., DuHadaway, J. B., Pigott, E., Manley, K., Prendergast, G. C., Laury‐Kleintop, L. D., & Mandik‐Nayak, L. (2017) · Clinical Immunology · doi:10.1016/j.clim.2017.01.016 · Cited by 48
Harper, J. L., Huot, N., Micci, L., Tharp, G. K., King, C. T., Rascle, P., Shenvi, N. V., Wang, H., Galardi, C. M., Upadhyay, A. A., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23189-7 · Cited by 48
Hybrid Immunity Shifts the Fc-Effector Quality of SARS-CoV-2 mRNA Vaccine-Induced Immunity
Bowman, K. A., Stein, D., Shin, S. A., Ferbas, K. G., Tobin, N. H., Mann, C. J., Fischinger, S., Saphire, E. O., Lauffenburger, D. A., Rimoin, A. W., et al. (2022) · mBio · doi:10.1128/mbio.01647-22 · Cited by 50
Martin, C. E., van Leeuwen, E. M. M., Im, S. J., Roopenian, D. C., Sung, Y.-C., & Surh, C. D. (2013) · Blood · doi:10.1182/blood-2012-08-449215 · Cited by 44
Entezam, M., Sanaei, M., Mirzaei, Y., Mer, A. H., Abdollahpour‐Alitappeh, M., Azadegan‐Dehkordi, F., & Bagheri, N. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121459 · Cited by 47
Deguine, J., Bréart, B., Lemaître, F., & Bousso, P. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1202065 · Cited by 51
Comparing the efficacy and neuroinflammatory potential of three anti-abeta antibodies
Fuller, J. P., Stavenhagen, J. B., Christensen, S., Kartberg, F., Glennie, M. J., & Teeling, J. L. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1484-2 · Cited by 44
“In humans, six FcγRs have been identified (activatory receptors, FcγRI, IIa, IIc, IIIa, an inhibitory receptor FcγRIIb and a GPI-linked decoy FcγRIIIb) and the ratio of activatory: inhibitory expression determines the activation threshold of effector cells [19].”
BackgroundB cells in spontaneous autoimmune diseases of the central nervous system
Berer, K., Wekerle, H., & Krishnamoorthy, G. (2010) · Molecular Immunology · doi:10.1016/j.molimm.2010.10.025 · Cited by 53
The Long Pentraxin PTX3 Promotes Fibrocyte Differentiation
Pilling, D., Cox, N., Vakil, V., Verbeek, J. S., & Gomer, R. H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119709 · Cited by 50
Viertlboeck, B. C., Schmitt, R., Hanczaruk, M. A., Crooijmans, R. P. M. A., Groenen, M. A. M., & Göbel, T. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.3.1533 · Cited by 47
“, Fc RIIb) in their cytoplasmic regions (3).”
BackgroundMethodInfluentialCross-presentation of IgG-containing immune complexes
Baker, K., Räth, T., Lencer, W. I., Fiebiger, E., & Blumberg, R. S. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1100-8 · Cited by 51
Development and Characterization of Monoclonal Antibodies Specific for Mouse and Human Fcγ Receptors
Tutt, A. L., James, S., Laversin, S. A., Tipton, T. R. W., Ashton‐Key, M., French, R. R., Hussain, K., Vaughan, A. T., Dou, L., Earley, A., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402988 · Cited by 53
Cheadle, E. J., Lipowska‐Bhalla, G., Dovedi, S. J., Fagnano, E., Klein, C., Honeychurch, J., & Illidge, T. (2016) · Leukemia · doi:10.1038/leu.2016.352 · Cited by 45
A novel bispecific DARP in targeting Fcγ RIIB and Fcε RI ‐bound IgE inhibits allergic responses
Zellweger, F., Gasser, P., Brigger, D., Buschor, P., Vogel, M., & Eggel, A. (2016) · Allergy · doi:10.1111/all.13109 · Cited by 44
Oldenburg, J., Kulkarni, R., Srivastava, A., Mahlangu, J. N., Blanchette, V. S., Tsao, E., Winding, B., Dumont, J., & Jain, N. (2017) · Haemophilia · doi:10.1111/hae.13353 · Cited by 50
CD32-Expressing CD4 T Cells Are Phenotypically Diverse and Can Contain Proviral HIV DNA
Martin, G. E., Pace, M. J., Thornhill, J. P., Phetsouphanh, C., Meyerowitz, J., Gossez, M., Hopkins, E., Brown, H., Robinson, N., Olejniczak, N. J., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00928 · Cited by 50
Gibbons, G. S., Kim, S., Wu, Q., Riddle, D. M., Leight, S. N., Changolkar, L. N., Xu, H. W., Meymand, E. S., O’Reilly, M., Zhang, B., et al. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00404-5 · Cited by 49
Brezski, R. J., Luongo, J. L., Petrone, D., Ryan, M. H., Zhong, D., Tam, S. H., Schmidt, A. P., Kruszynski, M., Whitaker, B., Knight, D. M., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.5.3183 · Cited by 44
LILRB4, an immune checkpoint on myeloid cells
Yang, T., Qian, Y., Liang, X., Wu, J., Zou, M., & Deng, M. (2022) · Blood Science · doi:10.1097/bs9.0000000000000109 · Cited by 48
“the g chain of FcgRI are necessary for eliciting immune functions such as phagocytosis, cytotoxicity, degranulation, antigen presentation and cytokine production.(54,55) FcgRI signal initiation occurs after cross-linking of the receptor complex, leading”
BackgroundLi, Y.-Y., Wen, W., Liu, Q., Wu, Q., Ren, P., Xi, X., Liu, H., Zhao, J., Zhang, W., Wang, Z., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-54810-0 · Cited by 46
FcγR requirements leading to successful immunotherapy
Dahal, L. N., Roghanian, A., Beers, S. A., & Cragg, M. S. (2015) · Immunological Reviews · doi:10.1111/imr.12342 · Cited by 48
The Chicken Leukocyte Receptor Complex Encodes a Family of Different Affinity FcY Receptors,
Viertlboeck, B. C., Schweinsberg, S., Schmitt, R., Herberg, F. W., & Göbel, T. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803060 · Cited by 43
“Almost all Ig isotypes are recognized by specific FcRs (1).”
BackgroundB-cell immunotherapeutics: emerging roles in solid organ transplantation
Jordan, S. C., Kahwaji, J. M., Toyoda, M., & Vo, A. A. (2011) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0b013e32834874f7 · Cited by 48
Julià, M., Guilabert, A., Lozano, F., Suárez-Casasús, B., Moreno, N., Carrascosa, J. M., Ferrándiz, C., Pedrosa, E., Alsina‐Gibert, M., & Mascaró, J. M. (2013) · JAMA Dermatology · doi:10.1001/jamadermatol.2013.4632 · Cited by 44
Combined analysis of genome-wide-linked susceptibility loci to Kawasaki disease in Han Chinese
Yan, Y., Ma, Y., Liu, Y., Hu, H., Shen, Y., Zhang, S., Ma, Y., Tao, D., Wu, Q., Peng, Q., et al. (2013) · Human Genetics · doi:10.1007/s00439-013-1279-2 · Cited by 45
Espéli, M., Clatworthy, M. R., Bökers, S., Lawlor, K. E., Cutler, A. J., Köntgen, F., Lyons, P., & Smith, K. G. C. (2012) · The Journal of Experimental Medicine · doi:10.1084/jem.20121752 · Cited by 43
Shannon, J. G., Cockrell, D. C., Takahashi, K., Stahl, G. L., & Heinzen, R. A. (2009) · BMC Immunology · doi:10.1186/1471-2172-10-26 · Cited by 44
“burnetii is FcR-dependent DC express multiple FcR on their surface and Ab-antigen complexes can stimulate DC through their interactions with a subset of these receptors [20].”
BackgroundGiorgini, A., Brown, H. J., Lock, H. R., Nimmerjahn, F., Ravetch, J. V., Verbeek, J. S., Sacks, S. H., & Robson, M. G. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.12.8745 · Cited by 43
Self-citationCox, N., Pilling, D., & Gomer, R. H. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400281 · Cited by 42
Castoldi, R., Jucknischke, U., Pradel, L. P., Arnold, E., Klein, C., Scheiblich, S., Niederfellner, G. J., & Sustmann, C. (2012) · Protein Engineering Design and Selection · doi:10.1093/protein/gzs048 · Cited by 43
“To fully exploit all antibody properties, Fc-containing scaffolds were chosen as these retain all possible effector functions and maintain the regular long serum half-life of an IgG antibody (Roopenian and Akilesh, 2007; Nimmerjahn and Ravetch, 2008).”
BackgroundIdentification of novel plasma glycosylation-associated markers of aging
Catera, M., Borelli, V., Malagolini, N., Chiricolo, M., Venturi, G., Reis, C. A., Osório, H., Abruzzo, P. M., Capri, M., Monti, D., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7059 · Cited by 49
“A good example is provided by the asparagine-linked (N-linked) sugar chain attached to Asn297 of IgG which, according to the presence or absence of specific terminal sugars, modulate the proor anti inflammatory properties of the antibody [9, 10].”
BackgroundOliviero, B., Mantovani, S., Varchetta, S., Mele, D., Grossi, G., Ludovisi, S., Nuti, E., Rossello, A., & Mondelli, M. U. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.01.032 · Cited by 46
Immunotherapy for acute myeloid leukemia (AML): a potent alternative therapy
Acheampong, D. O., Adokoh, C. K., Asante, D.-B., Asiamah, E. A., Barnie, P. A., Bonsu, D. N. O., & Kyei, F. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.10.100 · Cited by 46
Robinson, J. I., Baxter, E. W., Owen, R. L., Thomsen, M., Tomlinson, D. C., Waterhouse, M. P., Win, S. J., Nettleship, J. E., Tiede, C., Foster, R. J., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1707856115 · Cited by 49
“inhibitory receptors play a central role in the initiation and regulation of many immunological processes, including setting thresholds for B cell activation, recruitment of leukocytes, proinflammatory mediator release, phagocytosis and antibody-dependent cellular cytotoxicity (ADCC) (11, 12).”
BackgroundCD32 Ligation Promotes the Activation of CD4+ T Cells
Holgado, M. P., Sananez, I., Raiden, S., Geffner, J. R., & Arruvito, L. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02814 · Cited by 44
Caratelli, S., Arriga, R., Sconocchia, T., Ottaviani, A., Lanzilli, G., Pastore, D., Cenciarelli, C., Venditti, A., Principe, M. I. D., Lauro, D., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32663 · Cited by 44
“to be involved in capturing immune complexes in the peripheral blood.(2) CD32 is composed of three variants A, B and C.”
BackgroundNext generation of anti-PD-L1 Atezolizumab with enhanced anti-tumor efficacy in vivo
Li, M., Zhao, R., Chen, J., Tian, W., Xia, C., Liu, X., Li, Y., Yan, Y., Li, S., Sun, H., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-85329-9 · Cited by 48
The Amazing Transglycosylation Activity of Endo-β-N-Acetylglucosaminidases
Wang, L. (2011) · Trends in Glycoscience and Glycotechnology · doi:10.4052/tigg.23.33 · Cited by 49
Assessments of antibody biodistribution
Glassman, P. M., Abuqayyas, L., & Balthasar, J. P. (2015) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.365 · Cited by 42
Tonelli, R., Marchioni, A., Tabbì, L., Fantini, R., Busani, S., Castaniere, I., Andrisani, D., Gozzi, F., Bruzzi, G., Manicardi, L., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10050975 · Cited by 46
Targeting the high affinity receptor, FcγRI, in autoimmune disease, neuropathy, and cancer
Holtrop, T., Budding, K., Brandsma, A. M., & Leusen, J. H. W. (2022) · Immunotherapy Advances · doi:10.1093/immadv/ltac011 · Cited by 45
Broadly Neutralizing Antibodies Against HIV: New Insights to Inform Vaccine Design
Sadanand, S., Suscovich, T. J., & Alter, G. (2015) · Annual Review of Medicine · doi:10.1146/annurev-med-091014-090749 · Cited by 48
“F or p er so na l u se o nl y. Fab Fc IgM, IgD, IgG (1-4), IgA, IgE IgL IgH Fv Macrophage phagocytosis Complement activation Natural killer cell lysis Viral protein Infected cell FWR CDR Figure 1 Every antibody (Ab) contains two antigen-binding fragments (Fabs) and one crystallizable fragment (Fc).”
BackgroundInfluentialFrench, M. A., Wilson, K. M., Fleyfel, I., Fernández, S., Schorcht, A., Stratov, I., Kramski, M., Kent, S. J., & Kelleher, A. D. (2012) · AIDS · doi:10.1097/qad.0b013e32835cb720 · Cited by 44
Döbel, T., Kunze, A., Babatz, J., Tränkner, K., Ludwig, A., Schmitz, M., Enk, A., & Schäkel, K. (2013) · Blood · doi:10.1182/blood-2012-08-447045 · Cited by 42
Interaction of Two Phagocytic Host Defense Systems
Huang, Z.-Y., HUNTER, S. E., Chien, P., Kim, M.-K., Han-Kim, T.-H., Indik, Z. K., & Schreiber, A. D. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.163030 · Cited by 45
Fernandez-Vizarra, P., Lopez-Franco, O., Mallavia, B., Higuera-Matas, A., Lopez-Parra, V., Ortiz-Munoz, G., Ambrosio, E., Egido, J., Almeida, O. F. X., & Gomez-Guerrero, C. (2012) · Brain · doi:10.1093/brain/aws195 · Cited by 42
Ferguson, H. J. M., Wragg, J. W., Ward, S., Heath, V. L., Ismail, T., & Bicknell, R. (2016) · Oncotarget · doi:10.18632/oncotarget.7812 · Cited by 50
“The Fc tag enables interaction with the Fc receptors of circulating immune cells, thereby increasing the immune response against the fusion partner [18], in this case GRIN2D.”
Meinderts, S. M., Sins, J. W. R., Fijnvandraat, K., Nagelkerke, S. Q., Geissler, J., Tanck, M. W. T., Bruggeman, C. W., Biemond, B. J., Rijneveld, A. W., Kerkhoffs, J., et al. (2017) · Blood · doi:10.1182/blood-2017-05-784876 · Cited by 42
Turaj, A. H., Cox, K. L., Penfold, C. A., French, R. R., Mockridge, C. I., Willoughby, J. E., Tutt, A. L., Griffiths, J., Johnson, P., Glennie, M. J., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-20656-y · Cited by 45
Liu, X., Palaniyandi, S., Zhu, I., Tang, J., Li, W., Wu, X., Ochsner, S. P., Pauza, C. D., Cohen, J. I., & Zhu, X. (2019) · Nature Communications · doi:10.1038/s41467-019-10865-y · Cited by 46
The neutrophil: A key resourceful agent in immune‐mediated vasculitis
Aymonnier, K., Amsler, J., Lamprecht, P., Salama, A. D., & Witko‐Sarsat, V. (2022) · Immunological Reviews · doi:10.1111/imr.13170 · Cited by 48
“39,40 Furthermore, the integrin and complement receptor CR3 (CD11b/CD18) was shown to be required for a complete response.”
BackgroundCD16 Regulates TRIF-Dependent TLR4 Response in Human Monocytes and Their Subsets
Shalova, I. N., Kajiji, T., Lim, J. Y., Goméz-Piña, V., Fernández-Ruíz, I., Arnalich, F., Iau, P. T. C., López‐Collazo, E., Wong, S. C., & Biswas, S. K. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1100244 · Cited by 54
“Fcg receptors are known to bind to IgG immune complexes and modulate inflammatory response in monocytes/macrophages (45, 54).”
BackgroundKahn, F., Mörgelin, M., Shannon, O., Norrby‐Teglund, A., Herwald, H., Olin, A. I., & Björck, L. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000149 · Cited by 42
“HBP release, Fcc receptors, and the role of platelets To investigate the significance of Fcc receptor binding for HBP release, inhibition experiments were performed with antibodies against the various Fc receptors present on neutrophils (for references see reviews [25,26,27]).”
Methodvan Montfoort, N., Mangsbo, S. M., Camps, M. G. M., van Maren, W. W. C., Verhaart, I. E. C., Waisman, A., Drijfhout, J. W., Melief, C. J. M., Verbeek, J. S., & OSSENDORP, F. A. (2012) · European Journal of Immunology · doi:10.1002/eji.201141613 · Cited by 42
Norton, L. J., Zhang, Q., Saqib, K. M., Schrewe, H., Macura, K., Anderson, K. E., Lindsley, C. W., Brown, H. A., Rudge, S. A., & Wakelam, M. J. O. (2011) · Journal of Cell Science · doi:10.1242/jcs.082008 · Cited by 41
“Jo ur na l o f C el l S ci en ce Nimmerjahn and Ravetch, 2008).”
BackgroundFcRN receptor antagonists in the management of myasthenia gravis
Bhandari, V., & Bril, V. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1229112 · Cited by 44
“Cells of hemopoietic origin widely express receptors and can be either activating receptors (FcγRI, FcγRIIA, FcγRIIC, FcγRIIIA, and FcγRIIIB) or inhibitory receptors (FcγRIIB) and differ in their affinity to various IgG subclasses (47) FcRn belongs to the FcγRs is structurally unique and differs from the classic membe…”
BackgroundWilliams, E. L., Tutt, A. L., French, R. R., Chan, H. T. C., Lau, B., Penfold, C. A., Mockridge, C. I., Roghanian, A., Cox, K. L., Verbeek, J. S., et al. (2012) · European Journal of Immunology · doi:10.1002/eji.201142302 · Cited by 46
Interferon-inducible Ifi200-family genes as modifiers of lupus susceptibility
Choubey, D. (2012) · Immunology Letters · doi:10.1016/j.imlet.2012.07.003 · Cited by 44
French, M. A., Tanaskovic, S., Law, M. G., Lim, A. Y. F., Fernández, S., Ward, L. D., Kelleher, A. D., & Emery, S. (2010) · AIDS · doi:10.1097/qad.0b013e32833c1ce0 · Cited by 42
Brezski, R. J., Greenplate, A. R., Strake, B., & Jordan, R. E. (2011) · mAbs · doi:10.4161/mabs.3.6.18119 · Cited by 42
High Affinity Allele for the Gene of FCGR3A Is Risk Factor for HIV Infection and Progression
Poonia, B., Kijak, G. H., & Pauza, C. D. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015562 · Cited by 41
“The Fc receptors are a family of cell surface glycoproteins, which bind the constant regions (Fc) of soluble antibodies. They are implicated in diverse mechanisms of immune regulation. Cross-linking Fc receptors causes cell activation or inhibition depending on the individual receptor”
BackgroundFcγRΙΙB controls the potency of agonistic anti-TNFR mAbs
White, A. L., Chan, H. T. C., French, R. R., Beers, S. A., Cragg, M. S., Johnson, P., & Glennie, M. J. (2013) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-013-1398-6 · Cited by 49
Inui, M., Hirota, S., Hirano, K., Fujii, H., Sugahara-Tobinai, A., Ishii, T., Harigae, H., & Takai, T. (2015) · International Immunology · doi:10.1093/intimm/dxv009 · Cited by 41
Antigen modulation as a potential mechanism of anti-KEL immunoprophylaxis in mice
Liu, J., Santhanakrishnan, M., Natarajan, P., Gibb, D. R., Eisenbarth, S. C., Tormey, C. A., Siddon, A. J., Stowell, S. R., Branch, D. R., & Hendrickson, J. E. (2016) · Blood · doi:10.1182/blood-2016-06-724732 · Cited by 41
Hsieh, Y., Aggarwal, P., Cirelli, D. J., Gu, L., Surowy, T. K., & Mozier, N. M. (2016) · Journal of Immunological Methods · doi:10.1016/j.jim.2016.12.002 · Cited by 43
Marra, N. J., Richards, V. P., Early, A. M., Bogdanowicz, S. M., Bitar, P. D. P., Stanhope, M. J., & Shivji, M. S. (2017) · BMC Genomics · doi:10.1186/s12864-016-3411-x · Cited by 44
Modulation of Microglial Cell Fcγ Receptor Expression Following Viral Brain Infection
Chauhan, P., Hu, S., Sheng, W. S., Prasad, S., & Lokensgard, J. R. (2017) · Scientific Reports · doi:10.1038/srep41889 · Cited by 44
Nociceptive neuronal Fc-gamma receptor I is involved in IgG immune complex induced pain in the rat
Jiang, H., Shen, X., Chen, Z., Liu, F., Wang, T., Xie, Y., & Ma, C. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.03.001 · Cited by 41
“Among FccRs, FccRI (CD64) is the only high-affinity activating receptor for IgG immune complex (IgG-IC) (Nimmerjahn and Ravetch, 2006, 2008).”
BackgroundCD38-targeting antibodies in multiple myeloma: mechanisms of action and clinical experience
Frerichs, K. A., Nagy, N. A., Lindenbergh, P. L., Bosman, P., Soto, J. A. M., Broekmans, M. E. C., Groen, R. W. J., Themeli, M., Nieuwenhuis, L., Stege, C. A. M., et al. (2018) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2018.1443809 · Cited by 48
Current Concepts on 6-sulfo LacNAc Expressing Monocytes (slanMo)
Ahmad, F., Döbel, T., Schmitz, M., & Schäkel, K. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00948 · Cited by 42
“In lupus nephritis, intracapillary accumulation of immune complexes can prime the activation of Fc receptor-bearing myeloid cells (99, 104, 105).”
BackgroundTargeting Conventional Dendritic Cells to Fine-Tune Antibody Responses
Tesfaye, D. Y., Gudjonsson, A., Bogen, B., & Fossum, E. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01529 · Cited by 45
“In humans, IgG3 is one of the subtypes with high affinity for activating Fcγ-receptors, and consequently mediates strong effector functions (38).”
BackgroundInfluentialThe potential of engineered antibodies for HIV-1 therapy and cure
Grobben, M., Stuart, R. A., & van Gils, M. J. (2019) · Current Opinion in Virology · doi:10.1016/j.coviro.2019.07.007 · Cited by 47
Li, W., Yan, J., & Yu, Y. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1909870116 · Cited by 44
Predominant Role of Immunoglobulin G in the Pathogenesis of Splenomegaly in Murine Lupus
Zhang, Q., Xiang, L., Zaman, M. H., Dong, W., He, G., & Deng, G. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2019.03020 · Cited by 41
IL-4 controls activated neutrophil FcγR2b expression and migration into inflamed joints
Panda, S. K., Wigerblad, G., Jiang, L., Jiménez-Andrade, Y., Iyer, V. S., Shen, Y., Boddul, S. V., Guerreiro‐Cacais, A. O., Raposo, B., Kasza, Z., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1914186117 · Cited by 43
Dong, H., Yang, Y., Gao, C., Sun, H., Wang, H., Hong, C., Wang, J., Gong, F., & Gao, X. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2019-000339 · Cited by 47
Developing a 3D B Cell Lymphoma Culture System to Model Antibody Therapy
Foxall, R. B., Narang, P., Glaysher, B. R., Hub, E., Teal, E. L., Coles, M. C., Ashton‐Key, M., Beers, S. A., & Cragg, M. S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.605231 · Cited by 48
“Engagement of activatory FcgR on macrophages by mAb such as rituximab is proposed to play a key role in determining their anti-tumor efficacy (25, 26).”
BackgroundGresele, P., Momi, S., Marcucci, R., Ramundo, F., Stefano, V. D., & Tripodi, A. (2021) · Haematologica · doi:10.3324/haematol.2021.279289 · Cited by 44
Human IgG Subclasses:In VitroNeutralization of andIn VivoProtection against West Nile Virus
Hofmeister, Y., Planitzer, C. B., Farcet, M. R., Teschner, W., Butterweck, H. A., Weber, A., Holzer, G. W., & Kreil, T. R. (2010) · Journal of Virology · doi:10.1128/jvi.02155-10 · Cited by 41
Tanaka, M., Krutzik, S. R., Sieling, P. A., Lee, D. J., Rea, T. H., & Modlin, R. L. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0801683 · Cited by 41
Immunological memory in rheumatic inflammation - a roadblock to tolerance induction
Maschmeyer, P., Chang, H.-D., Cheng, Q., Mashreghi, M.-F., Hiepe, F., Alexander, T., & Radbruch, A. (2021) · Nature Reviews Rheumatology · doi:10.1038/s41584-021-00601-6 · Cited by 40
Cancer immunotherapies: A hope for the uncurable?
Hamdan, F., & Cerullo, V. (2023) · Frontiers in Molecular Medicine · doi:10.3389/fmmed.2023.1140977 · Cited by 45
Potential Therapeutic Value of the STING Inhibitors
Zhang, S., Zheng, R., Pan, Y., & Sun, H. (2023) · Molecules · doi:10.3390/molecules28073127 · Cited by 45
Antibody-mediated antigen loss switches augmented immunity to antibody-mediated immunosuppression
Jajosky, R. P., Patel, K., Allen, J. W. L., Zerra, P. E., Chonat, S., Ayona, D., Maier, C. L., Morais, D., Wu, S., Luckey, C. J., et al. (2023) · Blood · doi:10.1182/blood.2022018591 · Cited by 40
The chicken leukocyte receptor cluster
Viertlboeck, B. C., & Göbel, T. (2011) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2011.07.001 · Cited by 41
Dengue Virus Neutralization in Cells Expressing Fc Gamma Receptors
Chawla, T., Chan, K. R., Zhang, S. L.-X., Tan, H. C., Lim, A. P. C., Hanson, B. J., & Ooi, E. E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065231 · Cited by 40
Genetic Susceptibility to ANCA-Associated Vasculitis: State of the Art
Bonatti, F., Reina, M., Neri, T. M., & Martorana, D. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00577 · Cited by 47
Chicken IgY Binds Its Receptor at the CH3/CH4 Interface Similarly as the Human IgA:FcαRI Interaction
Pürzel, J., Schmitt, R., Viertlboeck, B. C., & Göbel, T. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901699 · Cited by 40
“Moreover, a massive expansion took place on chromosome 1, yielding an array of different affinity FcR with distinct tissue distributions and functional capabilities (31).”
BackgroundMatlawska‐Wasowska, K., Ward, E., Stevens, S., Wang, Y., Herbst, R., Winter, S. S., & Wilson, B. S. (2013) · Leukemia · doi:10.1038/leu.2013.5 · Cited by 42
Evaluation of Antibody-Dependent Cell Cytotoxicity Using Lactate Dehydrogenase (LDH) Measurement
Broussas, M., Broyer, L., & Goetsch, L. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-327-5_19 · Cited by 43
Antigen-presenting human B cells are expanded in inflammatory conditions
Shimabukuro‐Vornhagen, A., Garcia-Marquez, M. A., Fischer, R. N., Iltgen‐Breburda, J., Fiedler, A., Wennhold, K., Rappl, G., Abken, H., Lehmann, C., Herling, M., et al. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.5a0416-182r · Cited by 41
Genomic regulation of senescence and innate immunity signaling in the retinal pigment epithelium
Chaum, E., Winborn, C. S., & Bhattacharya, S. (2015) · Mammalian Genome · doi:10.1007/s00335-015-9568-9 · Cited by 41
“…phagocytosis, expression and secretion of inflammatory cytokines and chemokines, initiation of cell cycle arrest, and apoptosis (Gessner et al. 1998; Karsten and Kohl 2012; Murinello et al. 2014; Nimmerjahn and Ravetch 2008; Rittirsch et al. 2009; Schmidt and Gessner 2005; Syed et al. 2009).”
Imprime PGG-Mediated Anti-Cancer Immune Activation Requires Immune Complex Formation
Chan, A. S. H., Jonas, A. B., Qiu, X., Ottoson, N. R., Walsh, R. M., Gorden, K. B., Harrison, B., Maimonis, P. J., Leonardo, S. M., Ertelt, K. E., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0165909 · Cited by 42
Metadata
- Authors
- Nimmerjahn, F., & Ravetch, J. V.
- Affiliations
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- Rockefeller University (US)
- Venue
- Nature Reviews Immunology
- Published
- 2008-01
- Volume
- 8
- Issue
- 1
- Pages
- 34-47
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W2075901113
- Cited by
- 2,947
- References
- 139
- Citations by year
- 2026: 186 · 2025: 176 · 2024: 158 · 2023: 174 · 2022: 169 · 2021: 196 · 2020: 158 · 2019: 188 · 2018: 151 · 2017: 161 · 2016: 158 · 2015: 170 · 2014: 165 · 2013: 162 · 2012: 181
- FWCI
- 11.09
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deutsche Forschungsgemeinschaft
- National Institutes of Health
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Monoclonal and Polyclonal Antibodies Research
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
- Keywords
- Fc gamma receptor, IgG, antibody subclasses, immune regulation, therapeutic antibodies, autoimmune disease, infectious diseases, cancer immunotherapy, antibody effector functions
- MeSH terms
- Animals, Humans, Immunoglobulin G, Immunity, Receptors, Fc
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.